HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Engages Consumers To 'Buy Into' Brands On Digital Spend Boost

This article was originally published in The Rose Sheet

Executive Summary

Colgate targets at least 20% of its global media spending digitally as part of a larger marketing push to help counter marketplace uncertainties. It also is engaging in programs that create “meaning” for its brands and is engaging with consumers more on social media, says President and CEO Ian Cook.

You may also be interested in...



Oral Care Tops Colgate Priorities, Ad Spending Grows With Marketplace 'Uncertainty'

Colgate will boost its ad and promotional spend in 2017 “quite meaningfully” from 2016 to track with competitors' levels. "We focus in order of priority behind oral care, pet nutrition, personal care, and home care," says CEO Ian Cook.

Slimmed-Down P&G To Consist Of 65 ‘Leading Brands’ By FY 2017

At the CAGNY conference Feb. 19, P&G leadership provided new insight into the company’s streamlining program, specifically where the firm will end up after selling off 100 underperforming brands in deals expected to be closed by June 30, 2016. CFO Jon Moeller listed Gillette, Pantene, Head & Shoulders and Olay among core brands that will emerge from the simplification, highlighting recent innovations and marketing initiatives that are resonating with its core audience and driving growth.

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121191

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel